Effects of CYP2C9 polymorphism on the pharmacokinetics of irbesartan in healthy Korean subjects

被引：0
|
作者：
Kim, Mi-Jung
Bae, Jung -Woo
Han, Ho-Kyun
Choi, Sun-Ok
Kim, Ok-Hee
Jang, Choon-Gon
Lee, Jin-Hee
Kim, Nam-Tae
Lee, Seok-Yong
机构：
[1] Sungkyunkwan Univ, Coll Pharm, Seoul, South Korea
[2] Natl Inst Toxicol Res, Seoul, South Korea
来源：
ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷
关键词：
Irbesartan; CYP2C9; polymorphism; pharmacokinetics;
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [1] Effect of CYP2C9 polymorphism on the pharmacokinetics of candesartan in healthy Korean subjects.
    Lee, Seok-Yong
    Bae, Jung-Woo
    Han, Ho-Kyun
    Kim, Nam-Tae
    Lee, Jin-Hee
    Jang, Choon-Gon
    Jung, Dong-Won
    Lee, Hwan-Joo
    Choi, Sun-Ok
    Kim, Ok-Hee
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 235 - 235
  • [2] CYP2C9*3 and *13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects
    Chang-Ik Choi
    Mi-Jeong Kim
    Eun-Kyung Chung
    Hye-In Lee
    Choon-Gon Jang
    Jung-Woo Bae
    Seok-Yong Lee
    European Journal of Clinical Pharmacology, 2012, 68 : 149 - 154
  • [3] CYP2C9*3 and *13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects
    Choi, Chang-Ik
    Kim, Mi-Jeong
    Chung, Eun-Kyung
    Lee, Hye-In
    Jang, Choon-Gon
    Bae, Jung-Woo
    Lee, Seok-Yong
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (02) : 149 - 154
  • [4] Effect of CYP2C9 genetic polymorphism and breviscapine on losartan pharmacokinetics in healthy subjects
    Huang, Hang-Xing
    Wu, He
    Zhao, Yingying
    Zhou, Tao
    Ai, Xin
    Dong, Yu
    Zhang, Yan
    Lai, Yong
    XENOBIOTICA, 2021, 51 (05) : 616 - 623
  • [5] Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects
    Kim, Nam-Tae
    Cho, Chang-Keun
    Kang, Pureum
    Park, Hye-Jung
    Lee, Yun Jeong
    Bae, Jung-Woo
    Jang, Choon-Gon
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2022, 45 (02) : 114 - 121
  • [6] Effects of CYP2C9*3 and *13 alleles on the pharmacokinetics and pharmacodynamics of glipizide in healthy Korean subjects
    Nam-Tae Kim
    Chang‑Keun Cho
    Pureum Kang
    Hye-Jung Park
    Yun Jeong Lee
    Jung‑Woo Bae
    Choon-Gon Jang
    Seok-Yong Lee
    Archives of Pharmacal Research, 2022, 45 : 114 - 121
  • [7] Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects
    Li, Z.
    Wang, G.
    Wang, L. -S.
    Zhang, W.
    Tan, Z. -R.
    Fan, L.
    Chen, B. -L.
    Li, Q.
    Liu, J.
    Tu, J. -H.
    Hu, D. -L.
    Liu, Z. -Q.
    Zhou, H. -H.
    XENOBIOTICA, 2009, 39 (10) : 788 - 793
  • [8] Effect of CYP2C9*3 allele on the pharmacokinetics of naproxen in Korean subjects
    Jung-Woo Bae
    Ji-Hong Kim
    Chang-Ik Choi
    Mi-Jeong Kim
    Hyung-Ji Kim
    Seong-Ae Byun
    Young-Soon Chang
    Choon-Gon Jang
    Young-Seo Park
    Seok-Yong Lee
    Archives of Pharmacal Research, 2009, 32 : 269 - 273
  • [9] Effect of CYP2C9*3 allele on the pharmacokinetics of naproxen in Korean subjects
    Bae, Jung-Woo
    Kim, Ji-Hong
    Choi, Chang-Ik
    Kim, Mi-Jeong
    Kim, Hyung-Ji
    Byun, Seong-Ae
    Chang, Young-Soon
    Jang, Choon-Gon
    Park, Young-Seo
    Lee, Seok-Yong
    ARCHIVES OF PHARMACAL RESEARCH, 2009, 32 (02) : 269 - 273
  • [10] Effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of gliclazide in healthy subjects
    Kang, Pureum
    Cho, Chang-Keun
    Jang, Choon-Gon
    Lee, Seok-Yong
    Lee, Yun Jeong
    Choi, Chang-Ik
    Bae, Jung-Woo
    ARCHIVES OF PHARMACAL RESEARCH, 2023, 46 (05) : 438 - 447
12345